ATLANTA -- A tapered and pulsed course of vancomycin was not significantly better than a standard course of the drug for ...

Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation ...

Results at Six Months VCAS is a prospective, multicenter feasibility trial evaluating the safety and performance of the FieldForce Ablation System in patients with VT. Unlike conventional approaches, ...

As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors ...

According to Zomedica, a diagnostic and therapeutic products company, Assisi Loop Lounge is a bed that can relieve pain and ...

Stereotaxis STXS recently partnered with CardioFocus to develop the first robotic Pulsed Field Ablation (PFA) system for ...

Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ...

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, and CardioFocus, Inc., a medical device company dedicated to advancing ...

A novel pulsed-field ablation system, with the Varipulse catheter and the Trupulse generator (Biosense Webster), appeared to treat patients with drug-refractory paroxysmal atrial fibrillation (AF) ...

Introduction A substantial number of patients with major depressive disorder experience non-remission despite treatment with psychotherapy and several antidepressant drugs. This has increased the ...